Diabetes Devices Market Size

  • Report ID: 4642
  • Published Date: Oct 11, 2024
  • Report Format: PDF, PPT

Diabetes Devices Market Size

Diabetes Devices Market size was valued at USD 33.55 billion in 2024 and is set to reach USD 84.54 billion by the end of 2037, registering around 7.3% CAGR during the forecast period i.e., between 2025-2037. In the year 2025, the industry size of diabetes devices is assessed at USD 35.54 billion. The growing prevalence of diabetes across the world’s population and growing awareness about diabetes disease are estimated to drive the market’s growth during the forecast period. As per the American Diabetes Association estimations, in 2019, the total American population with diabetes was nearly 11.3 % of people i.e., about 37.3 million individuals.

In addition, one of the factors boosting the market's expansion is the rise in diabetes cases brought on by age, obesity, and bad lifestyle choices. According to the data reported, nearly 38 percent of adults across the globe are overweight as of 2019. Diabetes incidence is rising as a result of risk factors such as obesity and overweight. Therefore, it is anticipated that risk factors including smoking, being overweight or obese, and having high cholesterol levels will increase the prevalence of diabetes and increase the demand for diabetic devices. Numerous incentives, including a sizable ageing population, economical healthcare options, cost-effective labor, and relatively lax regulatory standards, are driving diabetic device manufacturers to grow their operations. To capture the largest possible proportion of the market, firms are now concentrating on harnessing opportunities existing in developing economies. Hence, these factors are highly expected to influence the global diabetes devices market’s growth positively over the projected period.


Diabetes Devices Market
Get more information on this report: Request Free Sample PDF

Browse Key Market Insights with Data Illustration:


Author Credits:  Radhika Pawar


  • Report ID: 4642
  • Published Date: Oct 11, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of diabetes devices is assessed at USD 35.54 billion.

The diabetes devices market size was valued at USD 33.55 billion in 2024 and is set to reach USD 84.54 billion by the end of 2037, registering around 7.3% CAGR during the forecast period i.e., between 2025-2037. Rising diabetes cases and the growing obese population across the world will boost the market growth.

North America industry is poised to account for largest revenue share by 2037, backed by increase in the prevalence of diabetes cases along with rising healthcare expenditure and the growing presence of dominant players in insulin syringe manufacturers in the region. 

The major players in the market include Medtronic plc, Abbott Laboratories, ARKRAY, Inc., Bayer AG, Lifescan, Inc., B. Braun Melsungen AG, Dexcom, Inc., Insulet Corporation, Ypsomed AG, Sanofi.
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample